In addition, we will construct an ovarian cancer xenograft tumor model and introduce STAT5A or JAK2 recombinant protein to verify the inhibition of MMP2 by high expression of STAT5A, thus affecting the invasion and migration ability of ovarian cancer. This evidence concerns the gene JAK2 and neoplasm.